Nurses and doctors support compassionate cannabis use in Wisconsin
Madison: At the Dec. 15 combined committee (cannabis) hearing on AB554/SB368, the Jacki Rickert Medical Marijuana Act, support from health care professionals, particularly those who treat patients in real pain or represent professions that do, was strong. This was evident to those attending the hearing and to those viewing it on Wisconsin Eye.
Unfortunately, the representative of the Wisconsin State Medical Society (SMS), Dr. Michael Miller, an addiction specialist with a lucrative practice treating people involuntarily referred for counseling after detection of marijuana use, was not among those supporting the JRMMA Dec. 15.
But even Dr. Miller's on record opposition on behalf of the SMS to the Jacki Rickert Medical Marijuana Act was tempered by statements he made. As to "gateway drugs", Dr. Miller identified tobacco, a legal substance, as the number one gateway drug. He also acknowledged not only had SMS members not been polled as to whether they supported the JRMMA, but if they were, "you might get a lot of members saying yes".
Daily Pot Smoking May Hasten Onset of Psychosis
Progression to daily marijuana use in adolescence may hasten the onset of symptoms leading up to psychosis, an Emory University study finds. The study was published in the November issue of the American Journal of Psychiatry.
The researchers analyzed data from 109 hospitalized patients who were experiencing their first psychotic episode. The results showed that patients who had a history of using marijuana, or cannabis, and increased to daily pot smoking experienced both psychotic and pre-psychotic symptoms at earlier ages.
"We were surprised that it wasn't just whether or not they used cannabis in adolescence that predicted the age of onset, rather it was how quickly they progressed to becoming a daily cannabis user that was the stronger predictor," said Michael Compton, lead author and assistant professor of psychiatry in the Emory School of Medicine.
The study also found a gender difference: The female subjects who progressed to daily pot smoking had a greater increased risk for the onset of psychosis than the males.
Marijuana tough on the teenage brain possibly leading to depression or just shedding a tear
According to a Canadian researcher, the effect of heavy doses of cannabis on young brains is more severe than expected.
Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre has completed a study that suggests smoking pot on a daily basis can cause depression and anxiety.
Notably, the activity can have an irreversible long-term effect on the brain.
“We wanted to know what happens in the brains of teenagers when they use cannabis and whether they are more susceptible to its neurological effects than adults,” explained Dr. Gobbi, who is also a professor at McGill University.
CANADA: Guelph cannabis club a smoking “business” — not far from Toronto
Rade Kovacevic runs the Medical Cannibis Club of Canada in Guelph where medicinal marijuana is available. Credit: Guelph Mercury
It’s a controversial operation but quietly so.
While it promotes itself and its workings via the internet, it guards its location closely. Even when you’ve arrived at the lobby of the downtown building where it’s situated – for now at least – only a simple sign marks its presence. White plastic letters on a brown board softly announce: Medical Club of Guelph.
The front door of the second-floor office is always locked. A doorbell chimes when a visitor wants access.
Behind the closed door, employees of the club – the Medical Cannabis Club of Guelph — dispense medical marijuana. It opened just over three years ago. It has quietly grown to 238 members.
The discreetness is to keep away those seeking recreational marijuana, said club founder Rade Kovacevic.
Marijuana, Alcohol Addiction May Share Genes
The genes that make people susceptible to alcoholism also make them prone to becoming addicted to marijuana, a new study suggests.
Researchers interviewed almost 6,300 men and women aged 24 to 36, including almost 2,800 sets of twins who were part of the Australian Twin Registry, about their use of alcohol and marijuana over their lifetime.
Twins are valuable to researchers in determining the role of genetics in various diseases or conditions because identical twins share 100 percent of their genes, while fraternal twins share 50 percent of their genes, the same as other siblings.
About 60 percent of the likelihood of becoming a heavy drinker, a frequent marijuana user or of becoming dependent on marijuana can be attributed to genes, according to the study, while about half of the likelihood of being an alcoholic can be traced to genetics.
Family life can lead to cannabis disorders, males more likely to smoke
No laughing matter: Males are more likely than females to have experienced cannabis abuse or dependence.
The findings reveal the characteristics of those who are more likely to experience a cannabis use disorder.
Half of the 21 year olds in the study reported having use of cannabis in their lifetime, and 21 percent were classified as ever having ever had a cannabis use disorder.
Males were much more likely than females to have experienced cannabis abuse or dependence.
Children whose mothers had frequently changed their marital status or who experience sexual abuse at childhood were more likely to develop a cannabis use disorder by 21 years.
Those who showed aggressive or delinquent behaviour at 14 years were more than twice as likely as other children to develop a cannabis use disorder by 21 years.
Young adults who reported poor academic performance, or have smoked a cigarette or consumed alcohol by 14 years were more likely to use and develop a cannabis disorder than others who have not.
2010 Will Be Even Better Than 2009 For Marijuana Advocates
Already Four States Have Marijuana Legalization Bills In Play; Californians To Vote On Legalization in 2010
It can readily be said that 2009 was one of the busiest and most productive years in cannabis law reform since NORML’s founding in 1970. However, it appears as if 2010 is going to be an even busier year–notably marked by the increasing number of actual state legalization bills and a voter initiative in America’s most important state.
Currently, there is legalization legislation pending in California, Massachusetts, Vermont, and a legalization bill was just introduced this week in Washington. Frankly, most of these bills do not have a strong prospect in passing this time out, however the immense public discussion that is generated is crucial for overall reform efforts.
The formula is simple: No public discussion or debate about legalization, obviously equates to no substantive law reforms. This is what regrettably happened in the United States, Canada and Europe from 1980-2000, buttressed by extreme federal anti-marijuanism in the form of the DARE program in the public school, the blitzkrieg of Partnership for a Drug-Free America ads polluting media airwaves and omnibus federal crime bills overloaded with severe and costly penalties (i.e., mandatory minimum sentencing, civil forfeiture, mass drug testing, etc…). However, since the turn of the century, there have been ever-increasing public discussions and debates about marijuana prohibition–principally driven by the creation and implementation of medical cannabis laws in thirteen states–which is leading to greater public support for reform.
Continue reading this article by Allen St. Pierre who is the Executive Director at NORML
RESEARCH: Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis
Cannabis therapy has been considered an effective treatment for spasticity, although clinical reports of symptom reduction in multiple sclerosis (MS) describe mixed outcomes. Recently introduced therapies of combined Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts have potential for symptom relief with the possibility of reducing intoxication and other side effects. Although several past reviews have suggested that cannabinoid therapy provides a therapeutic benefit for symptoms of MS, none have presented a methodical investigation of newer cannabinoid treatments in MS-related spasticity. The purpose of the present review was to systematically evaluate the effectiveness of combined THC and CBD extracts on MS-related spasticity in order to increase understanding of the treatment's potential effectiveness, safety and limitations.
Colorado’s Green Rush: Medical marijuana — nicknamed “Broadsterdam”
Zack Moore says he will make about $6,000 after six months of growing marijuana. Credit: CNN
Driving down Broadway, it's easy to forget you are in the United States. Amid the antique stores, bars and fast-food joints occupying nearly every block are some of Denver's newest businesses: medical marijuana dispensaries.
The locals call this thoroughfare "Broadsterdam." As in Amsterdam, Netherlands, these businesses openly advertise their wares, often with signs depicting large green marijuana leaves.
"The American capitalist system is working," said attorney and medical marijuana advocate Rob Corry.
It's a matter of supply and demand.
"The demand has always been there," he said, "and the demand is growing daily because more doctors are willing to do this, and now businesses, entrepreneurs, mom-and-pop shops are cropping up to create a supply."
Colorado voters legalized medical marijuana in 2000. For years, patients could get small amounts from "caregivers," the term for growers and dispensers who could each supply only five patients. In 2007, a court lifted that limit and business boomed.
Between 2000 and 2008, the state issued about 2,000 medical marijuana cards to patients. That number has grown to more than 60,000 in the last year.
State Sen. Chris Romer, a Democrat whose south Denver district includes Broadsterdam, said the state receives more than 900 applications a day.
"It's growing so fast, it's like the old Wild West," Romer said. "This reminds me of 1899 in Cripple Creek, Colorado, when somebody struck gold. Every 49er in the country is making it for Denver to open a medical marijuana dispensary."
They're calling it the Green Rush.
President Obama: Free the Medical Marijuana Researchers!
The War on Drugs continues, four decades after President Richard Nixon commenced hostilities. President Barack Obama--the third president in a row to have used illicit substances in his youth--is no drug warrior. However, he seems unlikely to challenge the disastrous new prohibition.
The president has, however, ended the federal campaign against medical marijuana, ordering administration officials to respect state laws legalizing the drug for medicinal purposes. This policy will grow increasingly important as more states allow use of med-pot (for instance, in November Maine voters legalized medical marijuana dispensaries). Congress should approve legislation introduced by Rep. Barney Frank (D-Mass.), codifying administration policy into law.
GNIF Review finds marijuana may help multiple sclerosis (MS) patients
Cancer patients, glaucoma patients and others can benefit from medical marijuana, and now a new analysis shows that it can help multiple sclerosis
(MS) patients find relief from the muscle spasms that are the hallmark of the debilitating autoimmune disease.
"The therapeutic potential of cannabinoids in MS appears to be comprehensive, and should be given considerable attention," said lead researcher Dr. Shaheen Lakhan, executive director of the Global Neuroscience Initiative Foundation.
"Spasticity, an involuntary increase in muscle tone or rapid muscle contractions, is one of the more common and distressing symptoms of MS," the researchers noted in their review. "Medicinal treatment may reduce spasticity, but may also be ineffective, difficult to obtain or associated with intolerable side effects," they added.
"We found evidence that cannabis plant extracts may provide therapeutic benefit for MS spasticity symptoms," Lakhan said.
Although some objective measures showed improvement, there were no significant changes in after-treatment assessments, Lakhan said. "However, subjective assessment of symptom relief did often show significant improvement post-treatment," he added.
